Rocket Pharmaceuticals, Inc. RCKT
NASDAQ · United States · Health Technology
$2.56-0.03 (-1.16%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-10 | 1.08 | 0.86 | +25.6% | $0 | -100.0% | -3.0%$3.61→$3.50 |
| Q1 2026 | 2026-05-07 | -0.42 | -0.41 | -2.4% | — | — | -6.0%$3.86→$3.63 |
| Q4 2025 | 2026-02-26 | -0.38 | -0.42 | +9.5% | — | — | +15.7%$4.33→$5.01 |
| Q3 2025 | 2025-11-06 | -0.45 | -0.48 | +6.2% | — | — | -4.5%$3.32→$3.17 |
| Q4 2024 | 2025-02-27 | -0.62 | -0.72 | +13.9% | — | — | — |
| Q2 2024 | 2024-08-05 | -0.74 | -0.72 | -2.8% | — | — | — |
| Q1 2024 | 2024-05-05 | -0.66 | -0.67 | +1.5% | — | — | — |
| Q4 2023 | 2024-02-25 | -0.64 | -0.77 | +16.9% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.